Loading
Loading…
Loading…
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | L1₹2.6 LQualified Make: IPRAVENT
Model: IPRATROPIUM BROMIDE 250 MCG/ML G 2 KRISHNA KUNJ III A 142 NEHRU NAGAR GHAZIABAD UTTAR PRADESH 201001 | GHAZIABAD | UTTAR PRADESH | 201001 | Make: IPRAVENT
Model: IPRATROPIUM BROMIDE 250 MCG/ML | L1 | Qualified MII |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
1 Sept 2025, 12:00 pmClosed
Ipratropium Bromide Respules (V2) (Q2) Tartrate + Timolol Maleate Drops (V2) (Q2) Tablets (V2) (Q2)
Bicalutamide Tablets (V2) (Q2) Tablet (Q2)
Hydroxyurea Capsule (Q2)
Micronized Progesterone Capsules (Q2) (Q2)
Tamoxifen Tablets (Q2)
Budesonide + Formoterol Fumarate Respules (V2) (Q2) (3 (3 ) ) Minimum Average Annual Turnover of the bidder (For 3 Years) 2 Lakh (s) ( ( 3 3 ))
8231839
Two Packet Bid
Ipratropium Bromide Respules (V2)
Mathura
Total value wise evaluation
PRODUCT
7 documents required · 7 mandatory
₹2 L
50%
Exempted
1 Sept 2025
1 Sept 2025
Ipratropium Bromide Respules (V2) (Q2) Tartrate + Timolol Maleate Drops (V2) (Q2) Tablets (V2) (Q2)
Bicalutamide Tablets (V2) (Q2) Tablet (Q2)
Hydroxyurea Capsule (Q2)
Micronized Progesterone Capsules (Q2) (Q2)
Tamoxifen Tablets (Q2)
Budesonide + Formoterol Fumarate Respules (V2) (Q2) (3 (3 ) ) Minimum Average Annual Turnover of the bidder (For 3 Years) 2 Lakh (s) ( ( 3 3 ))
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8231839.pdf
GEM_BID
atc_dc4c830e-b856-4e75-bf3e1755496289938_MSMHMTR.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .